<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">As a result of the re-emergence of these vaccine-preventable viruses, recent guidelines suggest vaccination with the measles, mumps, and rubella (MMR) vaccine 2 years following hematopoietic stem cell transplantation in patients without evidence of graft-versus-host disease [
 <xref ref-type="bibr" rid="CR120">120</xref>, 
 <xref ref-type="bibr" rid="CR121">121</xref>]. If at all possible, patients undergoing solid organ transplantation who do not have evidence of protection against measles and mumps (e.g., positive IgG antibody to each) should be vaccinated prior to the initiation of immunosuppressive therapy.
</p>
